Sanofi has entered into an agreement to acquire Blueprint Medicines Corp., a U.S.-based biopharma company specializing in ...

PharmaLogic Holdings Corp., a CDMO specialized in radiopharmaceuticals, has appointed Etienne Montagut, currently serving as ...

Sterling will manufacture cGMP clinical material for KIVU-107 at its bioconjugation facility in Deeside, UK. Kivu Bioscience, ...

Aims to advance cutaneous drug delivery into the skin for Epidermolysis Bullosa. DEBRA Research GmbH, a global non-profit ...

The CDMO's head of development talks about ADCs, accelerated timelines, and the push for end-to-end development services.